The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global nephrology and urology devices market exhibited moderate growth during 2015-2020. Nephrology and urology devices are medical equipment used for the treatment of kidney and urinary system-related diseases. Some of the commonly used devices include instruments and consumables, such as ureteral and percutaneous nephrostomy (PCN) catheters, urinary stents, vaginal meshes and slings, stone baskets, urology guidewires and renal dilators. These devices are widely used for hemo- and peritoneal dialysis, urinary stone removal, catheter ablation and sacral neuromodulation. They are used for treating any swellings or blockages in the urinary tract and find extensive applications across hospitals, clinics, dialysis centers and research laboratories.
The increasing prevalence of chronic diseases, including chronic kidney diseases (CKD), urinary incontinence, benign prostatic hyperplasia (BPH) and end-stage renal disease (ESRD), across the globe is one of the key factors driving the growth of the market. Moreover, the rising geriatric population, which is more susceptible to ailments, such as diabetes and prostate cancer, is providing a thrust to the market growth. With the growing consumer awareness regarding the effective treatment alternatives for such disorders, there is an escalating demand for minimally invasive (MI) devices manufactured using advanced biocompatible materials, such as nitinol, polyurethanes, polycarbonates and silicone. These materials provide superior kink resistance, smooth insertion capabilities and facilitate high flow rates with low vein and arterial pressure. Additionally, the widespread utilization of percutaneous methods for stone disintegration and extraction, prosthetics in urology and extracorporeal shockwave lithotripsy for early diagnosis and shorter treatment duration, are contributing to the market growth. Other factors, including rising healthcare expenditures, along with extensive research and development (R&D) activities, are anticipated to drive the market toward growth further. Looking forward, IMARC Group expects the global nephrology and urology devices market to grow at a CAGR of around 5% during the forecast period (2021-2026).
IMARC Group provides an analysis of the key trends in each sub-segment of the global nephrology and urology devices market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, product and end use.
Breakup by Product:
Breakup by End Use:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Boston Scientific Corp., Coloplast A/S, Cook Group Inc., Fresenius Medical Care AG & Co. KGaA, Medtronic plc, Nipro Corporation and Nxstage Medical Inc. (Fresenius Medical Care).
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at